FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On April 26, 2005
Table of Contents
Docket # Title
1981N-0033A Oral Health Care Drug Product; Oral Antiseptic Drug Products
1983P-0187 REFRAIN FROM APPROVAL POLYURETHANE CONTRACEPTIVE SPONGE
2003H-0432 Civil Money Penalty, Korangy Radiology Associates, PA
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
2004N-0463 Food Labeling: Prominence of Calories
2005P-0161 ANDA Suitability for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets
2005P-0162 ANDA suitability for Diphenoxylate Hydrochloride and Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/ 5 mL.
1981N-0033A Oral Health Care Drug Product; Oral Antiseptic Drug Products
PDN 1 HFC-1 to Olsson Frank and Weeda PC Vol #: 17
1983P-0187 REFRAIN FROM APPROVAL POLYURETHANE CONTRACEPTIVE SPONGE
PDN 2 HFD-001 to Associated Pharmacologists & Toxicologists Vol #: 1
2003H-0432 Civil Money Penalty, Korangy Radiology Associates, PA
MO 12 Hen\\\Korangy Radiology Associates, P.A., et al Vol #: 8
2004N-0456 Serving Sizes of Products that Can Reasonably be Consumed at One Eating Occasion; Updating of Reference Amounts Customarily Consumed; Approaches for Recommending Smaller Portion Sizes
C 37 J. E. Miller Vol #: 1
C 38 Dr. J. H. BoylesJr. Vol #: 1
C 39 Harriet Babcock Vol #: 1
C 40 I. Stupack Vol #: 1
C 41 L. K. Hunt Vol #: 1
C 42 M. M. Wood Vol #: 1
C 43 F. G. Norris Vol #: 1
LET 1 HFS-830 Vol #: 1
2004N-0463 Food Labeling: Prominence of Calories
C 24 I. Stupack Vol #: 1
2005P-0161 ANDA Suitability for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets
ACK 1 HFA-305 to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1
2005P-0162 ANDA suitability for Diphenoxylate Hydrochloride and Atropine Sulfate Oral Solution USP, 5 mg/ 0.05 mg/ 5 mL.
CP 1 Lachman Consultant Services, Inc. Vol #: 1

Page created on May 9, 2005 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management